 This study evaluated the effectiveness of trospium chloride extended release XR in obese female patients with overactive bladder OAB. Patients received either placebo and trospium chloride XR or placebo only. The study assessed the change from baseline in urinary frequency, urgency, and incontinence for trospium chloride XR versus a placebo-pill. The study was 14 weeks in duration. 